{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:13:48Z","timestamp":1777428828134,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1124\/jpet.107.121350","type":"journal-article","created":{"date-parts":[[2007,7,14]],"date-time":"2007-07-14T02:11:46Z","timestamp":1184379106000},"page":"308-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pharmacological Profile of Novel Acid Pump Antagonist 7-(4-Fluorobenzyloxy)-2,3-dimethyl-1-{[(1 S,2 S)-2-methyl cyclopropyl]methyl}-1 H-pyrrolo[2,3-d]pyridazine (CS-526)"],"prefix":"10.1016","volume":"323","author":[{"given":"Keiichi","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuyuki","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumi","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Morikawa-Inomata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuko","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Shibakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.107.121350_bib1","doi-asserted-by":"crossref","unstructured":"Beil W, Hackbarth I, and Sewing K-F (1986) Mechanism of gastric antisecretory effect of SCH28080. Br J Pharmacol 88: 19\u201323.","DOI":"10.1111\/j.1476-5381.1986.tb09466.x"},{"key":"10.1124\/jpet.107.121350_bib2","doi-asserted-by":"crossref","unstructured":"Blandizzi C, Natale G, Gherardi G, Lazzeri G, Marveggio C, Colucci R, Carignani D, and Del Tacca M (1999) Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury. Dig Dis Sci 44: 2039\u20132050.","DOI":"10.1023\/A:1026626519534"},{"key":"10.1124\/jpet.107.121350_bib3","doi-asserted-by":"crossref","unstructured":"Cheon HG, Lim H, and Lee DH (2001) Biochemical properties of a newly synthesized H+\/K+ ATPase inhibitor, 1-(2-methyl-4-methoxyohenyl)-4-[(3-hydroxypropyl)amino]-6-methyl-2,3-dihydropyrrolo[3,2-c]quinoline. Eur J Pharmacol 411: 181\u2013186.","DOI":"10.1016\/S0014-2999(00)00919-5"},{"key":"10.1124\/jpet.107.121350_bib4","doi-asserted-by":"crossref","unstructured":"DeVito RV and Harkins HN (1959) Techniques in Heidenhain pouch experiments. J Appl Physiol 14: 138\u2013139.","DOI":"10.1152\/jappl.1959.14.1.138"},{"key":"10.1124\/jpet.107.121350_bib5","doi-asserted-by":"crossref","unstructured":"Fiske CH and Subbarow Y (1925) The colorimetric determination of phosphorus. J Biol Chem 66: 375\u2013400.","DOI":"10.1016\/S0021-9258(18)84756-1"},{"key":"10.1124\/jpet.107.121350_bib6","doi-asserted-by":"crossref","unstructured":"Forte JG and Yao X (1996) The membrane-recruitment-and-recycling hypothesis of gastric HCl secretion. Trends Cell Biol 6: 45\u201348.","DOI":"10.1016\/0962-8924(96)81009-9"},{"key":"10.1124\/jpet.107.121350_bib7","doi-asserted-by":"crossref","unstructured":"Freston JW, Borch K, Brand SJ, Carlsson E, Creutzfeldt W, H\u00e5kanson R, Olbe L, Solcia E, Walsh JH, and Wolfe MM (1995) Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis. Dig Dis Sci 40: 50S\u201362S.","DOI":"10.1007\/BF02214871"},{"key":"10.1124\/jpet.107.121350_bib8","doi-asserted-by":"crossref","unstructured":"Gedda K, Briving C, Svensson K, Maxvall I, and Andersson K (2007) Mechanism of action of AZD0865, a K+-competitive inhibitor of gastric H+,K+-ATPase. Biochem Pharmacol 73: 198\u2013205.","DOI":"10.1016\/j.bcp.2006.09.020"},{"key":"10.1124\/jpet.107.121350_bib9","doi-asserted-by":"crossref","unstructured":"Goto Y and Kishi S (1989) Experimental model of acute esophagitis in the rat and comparison of effectiveness of antiulcer drugs including H2-antagonists and omeprazole. Jpn J Pharmacol 49: 193P.","DOI":"10.1016\/S0021-5198(19)56414-9"},{"key":"10.1124\/jpet.107.121350_bib10","doi-asserted-by":"crossref","unstructured":"Herling AW and Weidmann K (1994) Gastric H+\/K+-ATPase Inhibitors. Prog Med Chem 31: 233\u2013264.","DOI":"10.1016\/S0079-6468(08)70021-3"},{"key":"10.1124\/jpet.107.121350_bib11","doi-asserted-by":"crossref","unstructured":"Im WB and Blakeman DP (1982) Inhibition of gastric (H+ + K+)-ATPase by unsaturated long-chain fatty acids. Biochim Biophys Acta 692: 355\u2013360.","DOI":"10.1016\/0005-2736(82)90384-4"},{"key":"10.1124\/jpet.107.121350_bib12","doi-asserted-by":"crossref","unstructured":"Inatomi N, Nagaya H, Takami K, Shino A, and Satoh H (1991) Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats. Jpn J Pharmacol 55: 437\u2013451.","DOI":"10.1254\/jjp.55.437"},{"key":"10.1124\/jpet.107.121350_bib13","doi-asserted-by":"crossref","unstructured":"Keeling DJ, Malcolm RC, Laing SM, Ife RJ, and Leach CA (1991) SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase. Biochem Pharmacol 42: 125\u2013130.","DOI":"10.1016\/0006-2952(91)90690-7"},{"key":"10.1124\/jpet.107.121350_bib14","doi-asserted-by":"crossref","unstructured":"Keeling DJ, Taylor AG, and Schudt C (1989) The binding of a K+ competitive ligand, 2-methyl,8-(phenylmethoxy)imidazo(1,2-a)pyridine 3-acetonitrile, to the gastric (H+ + K+)-ATPase. J Biol Chem 264: 5545\u20135551.","DOI":"10.1016\/S0021-9258(18)83580-3"},{"key":"10.1124\/jpet.107.121350_bib15","doi-asserted-by":"crossref","unstructured":"Kromer W, Postius S, and Riedel R (2000) Animal pharmacology of reversible antagonism of the gastric acid pump, compared to standard antisecretory principles. Pharmacology 60: 179\u2013187.","DOI":"10.1159\/000028367"},{"key":"10.1124\/jpet.107.121350_bib16","doi-asserted-by":"crossref","unstructured":"Lamberts R, Creutzfeldt W, St\u00f6ckmann F, Jacubaschke U, Maas S, and Brunner G (1988) Long-term omeprazole treatment in man: effects on gastric endocrine cell populations. Digestion 39: 126\u2013135.","DOI":"10.1159\/000199615"},{"key":"10.1124\/jpet.107.121350_bib17","doi-asserted-by":"crossref","unstructured":"Lamberts R, Creutzfeldt W, Str\u00fcber HG, Brunner G, and Solcia E (1993) Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 104: 1356\u20131370.","DOI":"10.1016\/0016-5085(93)90344-C"},{"key":"10.1124\/jpet.107.121350_bib18","doi-asserted-by":"crossref","unstructured":"Larner AJ and Lendrum R (1992) Oesophageal candidiasis after omeprazole therapy. Gut 33: 860\u2013861.","DOI":"10.1136\/gut.33.6.860"},{"key":"10.1124\/jpet.107.121350_bib19","doi-asserted-by":"crossref","unstructured":"Lindberg P, Br\u00e4ndstr\u00f6m A, Wallmark B, Mattsson H, Rikner L, and Hoffmann K-J (1990) Omeprazole: the first proton pump inhibitor. Med Res Rev 10: 1\u201354.","DOI":"10.1002\/med.2610100102"},{"key":"10.1124\/jpet.107.121350_bib20","doi-asserted-by":"crossref","unstructured":"Lineweaver H and Burk D (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56: 658\u2013666.","DOI":"10.1021\/ja01318a036"},{"key":"10.1124\/jpet.107.121350_bib21","doi-asserted-by":"crossref","unstructured":"Mizui T and Doteuchi M (1983) Effect of polyamines on acidified ethanol-induced gastric lesions in rats. Jpn J Pharmacol 33: 939\u2013945.","DOI":"10.1016\/S0021-5198(19)52438-6"},{"key":"10.1124\/jpet.107.121350_bib22","doi-asserted-by":"crossref","unstructured":"Munson K and Sachs G (1988) Inactivation of H+,K+-ATPase by a K+-competitive photoaffinity inhibitor. Biochemistry 27: 3932\u20133938.","DOI":"10.1021\/bi00411a007"},{"key":"10.1124\/jpet.107.121350_bib23","doi-asserted-by":"crossref","unstructured":"Murakami M, Yoo JK, Inada M, and Miyake T (1988a) Effect of ammonia on the gastric mucosa in rats: pathophysiological importance of urease in gastric ulcer disease. Jpn J Pharmacol 47: 330\u2013332.","DOI":"10.1254\/jjp.47.330"},{"key":"10.1124\/jpet.107.121350_bib24","doi-asserted-by":"crossref","unstructured":"Murakami M, Yoo JK, Saita H, Seiki M, Inada M, and Miyake T (1988b) Effects of 16,16-dimethyl-prostaglandin E2 on ammonia- and ethanol-induced mucosal lesions in the rat. J Clin Gastroenterol 10: S65\u2013S71.","DOI":"10.1097\/00004836-198812001-00011"},{"key":"10.1124\/jpet.107.121350_bib25","doi-asserted-by":"crossref","unstructured":"Murakami M, Yoo JK, Teramura S, Yamamoto K, Saita H, Kita T, and Miyake T (1989) Protective effect of taurine against ammonia-induced gastric mucosal lesions in rats. Jpn J Pharmacol 51: 569\u2013571.","DOI":"10.1016\/S0021-5198(19)40084-X"},{"key":"10.1124\/jpet.107.121350_bib26","doi-asserted-by":"crossref","unstructured":"Nagaya H, Satoh H, Kubo K, and Maki Y (1989) Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749. J Pharmacol Exp Ther 248: 799\u2013805.","DOI":"10.1016\/S0022-3565(25)23774-0"},{"key":"10.1124\/jpet.107.121350_bib27","doi-asserted-by":"crossref","unstructured":"Natale G, Lazzeri G, Lubrano V, Colucci R, Vassalle C, Fornai M, Blandizzi C, and Del Tacca M (2004) Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. Toxicol Appl Pharmacol 195: 62\u201372.","DOI":"10.1016\/j.taap.2003.10.006"},{"key":"10.1124\/jpet.107.121350_bib28","doi-asserted-by":"crossref","unstructured":"Nishida A, Takinami Y, Yuki H, Kobayashi A, Akuzawa S, Kamato T, Ito H, Yamano M, Nagakura Y, and Miyata K (1994) YM022 {(R)-1-[2,3-dihydro-1-(2\u2032-methylphenacyl)-2-oxo-5-phenyl-1 H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea}, a potent and selective gastrin\/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats. J Pharmacol Exp Ther 270: 1256\u20131261.","DOI":"10.1016\/S0022-3565(25)22534-4"},{"key":"10.1124\/jpet.107.121350_bib29","doi-asserted-by":"crossref","unstructured":"Okabe S, Shimosako K, and Harada H (1995) Antisecretory effect of leminoprazole on histamine-stimulated gastric acid secretion in dogs: potent local effect. Jpn J Pharmacol 69: 91\u2013100.","DOI":"10.1254\/jjp.69.91"},{"key":"10.1124\/jpet.107.121350_bib30","doi-asserted-by":"crossref","unstructured":"Pope AJ, Boehm MK, Leach C, Ife RJ, Keeling D, and Parsons ME (1995) Properties of the reversible, K+-competitive inhibitor of the gastric (H+\/K+)-ATPase, SK&F 97574. I. In vitro activity. Biochem Pharmacol 50: 1543\u20131549.","DOI":"10.1016\/0006-2952(95)02020-9"},{"key":"10.1124\/jpet.107.121350_bib31","doi-asserted-by":"crossref","unstructured":"Pope AJ and Parsons ME (1993) Reversible inhibitors of the gastric H+\/K+-transporting ATPase: a new class of anti-secretory agent. Trends Pharmacol Sci 14: 323\u2013325.","DOI":"10.1016\/0165-6147(93)90004-4"},{"key":"10.1124\/jpet.107.121350_bib32","unstructured":"Robinson M (2001) New-generation proton pump inhibitors: overcoming the limitations of early-generation agents. Eur J Gastroenterol Hepatol 13: S43\u2013S47."},{"key":"10.1124\/jpet.107.121350_bib33","doi-asserted-by":"crossref","unstructured":"Robinson M (2005) Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases. Int J Clin Pract 59: 709\u2013715.","DOI":"10.1111\/j.1368-5031.2005.00517.x"},{"key":"10.1124\/jpet.107.121350_bib34","doi-asserted-by":"crossref","unstructured":"Sachs G, Carlsson E, Lindberg P, and Wallmark B (1988) Gastric H,K-ATPase as therapeutic target. Annu Rev Pharmacol Toxicol 28: 269\u2013284.","DOI":"10.1146\/annurev.pa.28.040188.001413"},{"key":"10.1124\/jpet.107.121350_bib35","doi-asserted-by":"crossref","unstructured":"Saita H, Murakami M, Dekigai H, Kusaka S, Asagoe K, Shigemoto K, and Kita T (1995) Suppression of acid secretion increases ammonia-induced gastric damage. Gastroenterology 108: A207.","DOI":"10.1016\/0016-5085(95)23487-X"},{"key":"10.1124\/jpet.107.121350_bib36","unstructured":"Tytgat GN (2001) Shortcomings of the first-generation proton pump inhibitors. Eur J Gastroenterol Hepatol 13: S29\u2013S33."},{"key":"10.1124\/jpet.107.121350_bib37","doi-asserted-by":"crossref","unstructured":"Wallmark B, Briving C, Fryklund J, Munson K, Jackson R, Mendlein J, Rabon E, and Sachs G (1987) Inhibition of gastric H+,K+-ATPase and acid secretion by SCH28080, a substituted pyridyl(1,2 a)imidazole. J Biol Chem 262: 2077\u20132084.","DOI":"10.1016\/S0021-9258(18)61620-5"},{"key":"10.1124\/jpet.107.121350_bib38","unstructured":"Wurst W and Hartmann M (1996) Current status of acid pump antagonists (reversible PPIs). Yale J Biol Med 69: 233\u2013243."}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524341114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524341114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.107.121350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:25:17Z","timestamp":1740003917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524341114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0022356524341114"],"URL":"https:\/\/doi.org\/10.1124\/jpet.107.121350","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Profile of Novel Acid Pump Antagonist 7-(4-Fluorobenzyloxy)-2,3-dimethyl-1-{[(1 S,2 S)-2-methyl cyclopropyl]methyl}-1 H-pyrrolo[2,3-d]pyridazine (CS-526)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.107.121350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}